Respiratory Care in Intensive Care Unit for Neuromuscular Patients
Modalities of Respiratory Care, Vital and Respiratory Prognosis in Neuromuscular Patients Admitted to an Intensive Care Unit for Respiratory Failure
1 other identifier
observational
300
1 country
4
Brief Summary
Retrospective multicentric observational study exploring the population of adult neuromuscular patients presenting a respiratory distress requiring their admission in an Intensive Care Unit (ICU) for ventilatory support. Research of markers associated with long term mortality and ventilatory status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 19, 2016
CompletedFirst Posted
Study publicly available on registry
October 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedAugust 29, 2017
August 1, 2017
1.2 years
August 19, 2016
August 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
number of death
until 2016.12.31
Secondary Outcomes (3)
Definitive long term invasive ventilatory support
until 2016.12.31
Mortality attributable to a respiratory issue
until 2016.12.31
Re-hospitalization in a ICU-Ward
until 2016.12.31
Study Arms (1)
Ventilatory support
Adult patients presenting a neuromuscular disease, with involvement of respiratory or bulbar muscles
Interventions
Initiation of mechanical ventilatory support, invasive or non-invasive, Or modification of mechanical ventilatory support (modification of the parameters of the device, change of material, switch from non-invasive to invasive)
Eligibility Criteria
Adult patients presenting a neuromuscular disease, with involvement of respiratory or bulbar muscles. Neuromuscular diseases concerned : Central or Peripheral metabolic, toxic, or inflammatory neuropathies, Central or peripheral neurodegenerative or hereditary disorders Myopathies, amongst them dystrophinopathies, myotonic dystrophies Myasthenia gravis Tetraplegy, consequence of cervical spinal cord injury
You may qualify if:
- Patient \> 18 years old
- First stay in a ICU ward
- Presenting an acute respiratory distress at admission or during ICU stay
- Diagnosis of neuromuscular disease confirmed before Hospital discharge
You may not qualify if:
- Absence of respiratory failure during ICU stay (ICU stay for monitoring or for a specialized invasive procedure in the absence of respiratory failure, for example)
- Neuromuscular disease not proven or uncertain diagnosis
- Anterior admission in ICU ward for vital organ failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
CHU Clermont Ferrand
Clermont-Ferrand, France
CHU Grenoble
Grenoble, France
Hôpital de la Croix Rousse
Lyon, France
Hôpital Nord CHU St Etienne
Saint-Etienne, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2016
First Posted
October 18, 2016
Study Start
August 1, 2016
Primary Completion
October 1, 2017
Study Completion
October 1, 2017
Last Updated
August 29, 2017
Record last verified: 2017-08